T. Rowe Price Associates’s Terns Pharmaceuticals TERN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$297K Buy
2025
Q1
$210K Sell
2024
Q4
$8.34M Buy
2024
Q3
$12.3M Buy
2024
Q2
$182K Buy
2024
Q1
$136K Buy
2023
Q4
$120K Buy
2023
Q3
$90K Buy
2023
Q2
$149K Buy